Jabbour Jerome D
SEC insider (Form 3/4/5 filer). CIK 0001698838. Director at Indaptus Therapeutics, Inc. (INDP) and 1 other issuer. 2 reported Form 4/5 transactions since Sep 2024; latest on Feb 26, 2026. Located in NEW YORK, NY.
Companies Jabbour Jerome D has filed insider reports for
- Indaptus Therapeutics, Inc. (INDP): Director
- Matinas BioPharma Holdings, Inc. (MTNB): Director, Officer, President and CEO
Jabbour Jerome D
CIK: 0001698838
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
